The Europe newborn screening market is on a surging trend and is expected to evolve further with a CAGR of 13.22% over the forecast years of 2019-2027, owing to government agendas supporting newborn screening, rising popularity of sickle cell diseases in newborn babies, government’s needed regulation supporting new-born testing and technological advancement in newborn screening techniques.

EUROPE NEWBORN SCREENING MARKET FORECAST 2019-2027

Europe Newborn Screening Market By Product (new-born Screening Instruments, New-born Screening Reagents & Assay Kits) By Test Type (hearing Screen Test, Critical Congenital Heart Disease (cchd) Test, Dry Blood Spot Test) By Technology (tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, Dna Based Assays, Electrophoresis, Others) By Geography.

Request free sample

The Europe newborn screening market is on a surging trend and is expected to evolve further with a CAGR of 13.22% over the forecast years of 2019-2027, owing to government agendas supporting newborn screening, rising popularity of sickle cell diseases in newborn babies, government’s needed regulation supporting new-born testing and technological advancement in newborn screening techniques.

The Europe newborn screening market mainly covers countries such as the United Kingdom, France, Italy, Russia, Germany, Spain and Rest of Europe. The market finds its application in the healthcare sector, especially in hospitals and clinics across Europe.

There has been a steady rise in France where the authority mandates and regulates newborn screening specifically for five congenital diseases such as Sickle cell anemia, Cystic fibrosis, Phenylketonuria, Congenital Adrenal Hyperplasia, and Congenital Hypothyroidism. This is further contributing to the overall European market.

Government projects supporting technological advancement in the field of newborn screening are driving the German market, while the Rest of Europe market, which includes countries like Netherlands, Hungary, Belgium, Greece, Denmark, Ireland, Poland, and Sweden, is being propelled by government recommendations related to neonatal screening.

Major companies dealing in this market include Sciex, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., GE Healthcare Limited, Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Medtronic PLC, Thermo Fisher Scientific Inc., Neogen Labs Pvt. Ltd., Perkinelmer Inc., Zentech S.A., Waters Corporation and Trivitron Healthcare.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
        • GROWTH IN DRY BLOOD SPOT TEST
        • TECHNIQUES USED IN NEWBORN SCREENING TESTS
    1. MARKET DYNAMICS
      • ETYMOLOGY OF NEWBORN SCREENING
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • INCREASE IN OCCURRENCES OF NEWBORN DISEASES
        • GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
        • BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
        • RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
      • MARKET RESTRAINTS
        • ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
        • SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
      • MARKET OPPORTUNITIES
        • INCREASING FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH
        • NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
        • TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
        • INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
      • MARKET CHALLENGES
        • DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
        • MAINTENANCE OF EQUIPMENT IN HOSPITAL
    1. MARKET BY PRODUCT
      • NEW-BORN SCREENING INSTRUMENTS
      • NEW-BORN SCREENING REAGENTS & ASSAY KITS
    2. MARKET BY TEST TYPE
      • HEARING SCREEN TEST
      • CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
      • DRY BLOOD SPOT TEST
    3. MARKET BY TECHNOLOGY
      • TANDEM MASS SPECTROMETRY
      • PULSE OXIMETRY
      • ENZYME BASED ASSAYS
      • DNA BASED ASSAYS
      • ELECTROPHORESIS
      • OTHERS
    4. KEY ANALYTICS
      • PORTER’S FIVE FORCE MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE
        • BARGAINING POWER OF SUPPLIERS
        • BARGAINING POWER OF BUYERS
        • THREAT OF COMPETITIVE RIVALRY
      • KEY BUYING CRITERIA
        • RELIABILITY
        • COST
        • AVAILABILITY
        • TECHNOLOGICAL ADVANCEMENT
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL SUPPLIERS
        • MANUFACTURERS
        • DISTRIBUTORS
        • END-USERS
      • LEGAL, POLICY & REGULATORY FRAMEWORK
    5. EUROPE
      • UNITED KINGDOM
      • FRANCE
      • ITALY
      • RUSSIA
      • SPAIN
      • GERMANY
      • REST OF EUROPE
    6. COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
      • CORPORATE STRATEGIES
        • PRODUCT LAUNCH
      • COMPANY PROFILES
        • SCIEX
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • BIOTEK INSTRUMENTS INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • BIO-RAD LABORATORIES INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • CARDINAL HEALTH INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • GE HEALTHCARE LIMITED
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • AGILENT TECHNOLOGIES INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • MASIMO CORPORATION
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • NATUS MEDICAL INCORPORATED
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • MEDTRONIC PLC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • THERMO FISHER SCIENTIFIC INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • NEOGEN LABS PVT. LTD.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • PERKINELMER INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • ZENTECH S.A.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • WATERS CORPORATION
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • TRIVITRON HEALTHCARE
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS

     

    TABLE LIST

    TABLE 1. EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

    TABLE 2. EUROPE INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS

    TABLE 3. INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATH/ 1000 LIVE BIRTHS)

    TABLE 4. EUROPE NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)

    TABLE 5. EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027, (IN $ MILLION)

    TABLE 6. EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)

    TABLE 7. OPPORTUNITY MATRIX

    TABLE 8. VENDOR LANDSCAPE

    TABLE 9. REGULATORY FRAMEWORK

    TABLE 10. EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027, (IN $ MILLION)

    TABLE 11. LIST OF PRODUCT LAUNCHES

    FIGURE LIST 

    FIGURE 1. EUROPE NEW-BORN SCREENING INSTRUMENTS MARKET, BY TECHNOLOGY, 2018 & 2027 (IN %)

    FIGURE 2. CAUSES OF DEATH AMONG NEWBORNS EUROPE (0-27 DAYS)

    FIGURE 3. FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) 2017

    FIGURE 4. EUROPE NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)

    FIGURE 5. EUROPE NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)

    FIGURE 6. EUROPE NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)

    FIGURE 7. EUROPE NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)

    FIGURE 8. EUROPE NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)

    FIGURE 9. EUROPE NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)

    FIGURE 10. EUROPE NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)

    FIGURE 11. EUROPE NEWBORN SCREENING MARKET, BY ENZYME BASED ASSAYS, 2019-2027 (IN $ MILLION)

    FIGURE 12. EUROPE NEWBORN SCREENING MARKET, BY DNA BASED ASSAYS, 2019-2027 (IN $ MILLION)

    FIGURE 13. EUROPE NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)

    FIGURE 14. EUROPE NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

    FIGURE 15. PORTER’S FIVE FORCE ANALYSIS

    FIGURE 16. KEY BUYING IMPACT ANALYSIS

    FIGURE 17. VALUE CHAIN ANALYSIS

    FIGURE 18. EUROPE NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

    FIGURE 19. UNITED KINGDOM NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

    FIGURE 20. FRANCE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

    FIGURE 21. ITALY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

    FIGURE 22. RUSSIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

    FIGURE 23. SPAIN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

    FIGURE 24. GERMANY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

    FIGURE 25. REST OF EUROPE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

    FIGURE 26. INDUSTRY PLAYER POSITIONING IN 2018 (IN %)

    1. EUROPE
      • UNITED KINGDOM
      • FRANCE
      • ITALY
      • RUSSIA
      • SPAIN
      • GERMANY
      • REST OF EUROPE
    2. MARKET BY PRODUCT
      • NEW-BORN SCREENING INSTRUMENTS
      • NEW-BORN SCREENING REAGENTS & ASSAY KITS
    3. MARKET BY TEST TYPE
      • HEARING SCREEN TEST
      • CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
      • DRY BLOOD SPOT TEST
    4. MARKET BY TECHNOLOGY
      • TANDEM MASS SPECTROMETRY
      • PULSE OXIMETRY
      • ENZYME BASED ASSAYS
      • DNA BASED ASSAYS
      • ELECTROPHORESIS
      • OTHERS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type